Opportunity

Simpler Grants.gov #RFA-HG-27-007

NIH research awards to study how genomic variants affect genome function and phenotype

Buyer

National Institutes of Health

Posted

October 09, 2026

Respond By

December 14, 2026

Identifier

RFA-HG-27-007

NAICS

541714, 541715

The National Institutes of Health (NIH) seeks research applications to determine how genomic variants influence genome function and phenotype. - Buyer: National Institutes of Health (NIH); no specific institute, sub-agency, or office is identified. - Opportunity: Cooperative-agreement research to systematically perturb genomic variants or elements using high-throughput methods and measure effects on DNA, RNA, protein-coding elements, and molecular, cellular, or organismal phenotypes. - Research outputs: Robust, reproducible, portable data-processing pipelines and resources that can be made broadly accessible. - Consortium coordination: Awardees will join the Impact of Genomic Variation on Function (IGVF) Consortium and coordinate assays, variants, cell types, resources, and analysis strategies. - Funding: $15 million in total program funding is anticipated, with five awards expected and a maximum of $2 million per award. - Requirements: Clinical trials are not allowed. Foreign organizations and components may participate, but applications involving foreign subawards or subcontracts are not eligible for funding. - OEMs, vendors, and products: None named; no specific products, part numbers, or quantities are requested.

Description

This funding opportunity solicits applications to characterize genomic variation and assess how individual variants affect genome function. Work includes systematically perturbing variants or elements using high-throughput methods, collecting data on their effects across molecular, cellular, or organismal phenotypes, and developing robust, reproducible, portable data-processing pipelines. Funded centers will join the Impact of Genomic Variation on Function Consortium and collaborate on shared resources, assays, variants, cell types, and analysis strategies. The source lists total program funding of $15,000,000, five expected awards, and an award maximum of $2,000,000.

View original listing